Methodology · Private Equity · Deal Sequencing | Aug 11, 2026 | 7 min read
Nobody in private equity thinks quality of earnings is a bad instrument. It is one of the few things in a transaction that does exactly what it claims to do.
The problem is where it sits in the calendar.
A QoE validates the price. It is commissioned after the price has been indicated — after the deal team has formed a view, after the letter of intent, after exclusivity has started running. The instrument that tells you whether the number is real arrives downstream of the decision it exists to inform.
The cost allocation runs inverse to the risk
A QoE engagement costs five figures, often six on a larger transaction, and takes three to six weeks. That price is entirely reasonable for the work. It is also the reason the instrument cannot be deployed where it is most needed.
Consider how a mid-market firm actually allocates it. The platform acquisition at $180M enterprise value gets a full QoE, because the cheque justifies the fee and the partnership demands it. The third bolt-on this quarter at $14M does not — the engagement would be a meaningful percentage of the equity, and the deal team has three other things running.
Now consider where the errors actually live.
The $180M target has been prepared for sale by a banker. Its bridge is professionally assembled, its adjustments are conventional, its data room is complete. The $14M add-on is owned by a founder with a part-time bookkeeper and an advisor who has done six deals. Its bridge is informal, its add-backs are unexamined, and nobody has ever stress-tested its working capital.
Scrutiny is allocated to the deals most likely to survive it. That is not a failure of judgment by anyone involved. It is what happens when the only available instrument is priced as a late-stage engagement.
Three things that get conflated
Ask a deal team what a QoE does and you get three different answers, usually from the same person in the same conversation.
“Does the adjusted EBITDA in the CIM match the model, the management presentation and the lender deck?”
Cheap. Fast. Requires no new data. Nobody needs three weeks to answer it.
“Does each add-back trace to ledger entries, and does it survive a widened look-back?”
Moderate effort, high yield. This is where most surprises actually surface.
“Is this an independent accounting opinion a lender and a board can rely on?”
The expensive one. It is also the only one that genuinely needs three to six weeks.
Only the third requires a full engagement. The first two are screening, and screening is being priced as though it were attestation — which is why it gets skipped on anything below a threshold.
Separate them and the sequencing problem largely dissolves. Reconciliation belongs before the indication of interest. Substantiation belongs before the LOI. Attestation stays exactly where it is, under exclusivity, doing the job it is good at.
What the current sequence actually costs
The cost is not usually a blown deal. Blown deals are visible and get discussed. The cost is quieter than that.
Leverage transfers at the LOI. Before you sign, walking away is free. After, walking away has a cost and re-pricing has a reputation. Every finding that could have surfaced pre-LOI but surfaced in week four of exclusivity is a finding you now have to negotiate from the weaker side of the table.
Re-trades read as bad faith even when they are correct. A buyer who reduces price on a genuine QoE finding is doing exactly what diligence is for. It still costs them with that banker, and bankers have long memories and short lists.
And on a buy-and-build, the error compounds. Six add-ons in eighteen months, none individually large enough to justify a full engagement, each contributing a small unexamined adjustment to the platform’s aggregate EBITDA. That number is what gets sold at exit — where a sophisticated buyer’s advisors, who have commissioned the full engagement, will find it and reprice it at their multiple.
Math does not care which stage of the process failed to catch it.
What screening before the LOI actually looks like
Three questions, answerable from documents already in your possession:
- Does the adjusted EBITDA reconcile across all four documents? The CIM, the model, the management presentation, the lender deck. Where those four disagree, the disagreement is the finding — regardless of which one turns out to be right.
- Does every add-back trace to ledger entries rather than to a summary schedule? A schedule prepared by a sell-side advisor is an assertion. The ledger is the record. Anything that stops at the schedule goes on a challenge list.
- Do the “non-recurring” items stay non-recurring when you widen the window past the period the seller selected? Recurrence is only visible on a long enough look-back, and the look-back is the seller’s most powerful lever.
None of this replaces a QoE. It changes what the QoE is for — confirming a thesis you have already tested, rather than discovering one you have already priced.
Where the infrastructure argument sits
This is the part where most tools overreach, so let me be precise about what is and is not being claimed.
askOdin does not issue a quality of earnings opinion. We are not a CPA firm and an attestation is not a thing software produces. What deterministic verification does is collapse the cost of the first two layers — reconciliation and substantiation — to the point where they can run on every look rather than on the deals that already cleared conviction.
When the same adjusted EBITDA has to appear identically across four documents, a machine can check all four in the time it takes to open them. When an add-back claims to be non-recurring, the full look-back either supports that or it does not. Neither question needs three weeks. Both are currently waiting behind an engagement that does.
That is the Clarity Framework™ applied at the top of the funnel instead of the bottom — cross-examination rather than summarisation, with every figure anchored to its source in the Provenance Ledger.
The instrument is not the problem. Its position in the calendar is.
Related reading: Quality of Earnings — full definition · The EBITDA Illusion · The Second Negotiation · AI Quality of Earnings